Standard Biotools (LAB) Long-Term Debt Repayments (2021 - 2024)
Historic Long-Term Debt Repayments for Standard Biotools (LAB) over the last 6 years, with Q4 2024 value amounting to $55.0 million.
- Standard Biotools' Long-Term Debt Repayments rose 430000.0% to $55.0 million in Q4 2024 from the same period last year, while for Sep 2025 it was $55.0 million, marking a year-over-year increase of 48250.37%. This contributed to the annual value of $63.2 million for FY2024, which is 293370.14% up from last year.
- Latest data reveals that Standard Biotools reported Long-Term Debt Repayments of $55.0 million as of Q4 2024, which was up 430000.0% from $8.2 million recorded in Q1 2024.
- Standard Biotools' 5-year Long-Term Debt Repayments high stood at $55.0 million for Q4 2024, and its period low was $501000.0 during Q1 2021.
- In the last 4 years, Standard Biotools' Long-Term Debt Repayments had a median value of $4.0 million in 2022 and averaged $12.1 million.
- As far as peak fluctuations go, Standard Biotools' Long-Term Debt Repayments skyrocketed by 126487.03% in 2022, and later soared by 430000.0% in 2024.
- Standard Biotools' Long-Term Debt Repayments (Quarter) stood at $501000.0 in 2021, then soared by 1264.87% to $6.8 million in 2022, then crashed by 81.72% to $1.2 million in 2023, then skyrocketed by 4300.0% to $55.0 million in 2024.
- Its Long-Term Debt Repayments stands at $55.0 million for Q4 2024, versus $8.2 million for Q1 2024 and $1.2 million for Q4 2023.